cvs caremark tirzepatide hit with lawsuit over dropping Zepbound from formulary In 2025, CVS Caremark excluded

However, its essential to manage any adverse effects to ensure they do not interfere with daily life or overall health

22 of the subjects completed the study (74)

Participants in the trial had obesity or were overweight with weight-related health conditions

Some people also experience increased heart rate or changes to their glucose metabolism

Both the SURMOUNT and The SURPASS clinical trials examined the effects of Tirzepatide in thousands of patients, demonstrating its safety and clinically significant benefits (2, 4)

By customizing the dosage to fit each patients needs, semaglutide effectively regulates appetite and blood sugar, encouraging sustainable weight loss